Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Short term Debt: 2009-2023

Historic Short term Debt for Ironwood Pharmaceuticals (IRWD) over the last 6 years, with Dec 2023 value amounting to $199.6 million.

  • Ironwood Pharmaceuticals' Short term Debt was N/A to $199.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $199.5 million, marking a year-over-year change of. This contributed to the annual value of $199.6 million for FY2023, which is N/A change from last year.
  • Ironwood Pharmaceuticals' Short term Debt amounted to $199.6 million in FY2023, which was up 70.77% from $116.9 million recorded in FY2021.
  • In the past 5 years, Ironwood Pharmaceuticals' Short term Debt ranged from a high of $199.6 million in FY2023 and a low of $116.9 million during FY2021.
  • Moreover, its 2-year median value for Short term Debt was $158.2 million (2021), whereas its average is $158.2 million.